Delivery Order SPE2DB20D1109-SPE2DB24FP52E
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $11,837.68 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a period of performance through December 30, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,191.60, is for the delivery of RABAVERT rabies vaccine with diluents. The contract has a completion date of January 28, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation on this award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,790.90 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,029.90, is for the delivery of RABAVERT Rabies Vaccine with Diluents. It is a firm fixed-price contract with an ultimate completion date of August 5, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office division on September 5, 2024. The $1,890.84 Firm Fixed Price contract is for the supply of RABAVERT RABIES VACC W-DILUENTS, a critical pharmaceutical product. This contract has a performance period through September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering these vaccines and associated supplies to support healthcare needs across the...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The award, valued at $35,517.52, has an ultimate completion date of April 1, 2024. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government, is for the delivery of RABAVERT rabies vaccine with diluents. The $1,158.18 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 26, 2024 with a completion date of June 27, 2024. The contract does not have a set-aside designation. AmerisourceBergen also holds a larger...
This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RABAVERT rabies vaccine with diluents. The delivery order, valued at $14,091.19, has a performance period through March 29, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which is part of a larger DLA indefinite delivery contract (IDC) valued up to $999,999,999.00 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,095.80 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,461.05, is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a rabies vaccine. The contract is a Firm Fixed Price Delivery Order with a performance period ending on January 22, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...